Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$184.2M
+12165.9% from 2023
Prescriptions
8,670
$21,242.10 per claim
Patients
2,247
2,035 prescribers
Total spending, 2024
$184.2M
$81,962.18 per patient
Medicare prescription drug plans paid $184.2M for Truqap in 2024, for 8,670 prescriptions and refills to 2,247 patients (up 12165.9% from 2023). The average cost per claim was $21,242.10.
California had the highest Medicare cost for Truqap in 2024: $28.0M for 1,302 claims, followed by New York ($17.4M).
Igor Makhlin, hematology-oncology in Philadelphia, PA, had the highest Medicare cost for Truqap in 2024: 54 claims costing $1.2M.
Truqap is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Igor Makhlin Philadelphia, PA | Hematology-Oncology | 54 | 11 | $1.2M |
| Jacqueline F Bromberg New York, NY | Medical Oncology | 34 | Under 11 | $755K |
| Rowena D Meyer |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 55 | 61 | 56 | $1.5M |
| 2024 | 2,035 | 8,670 | 2,247 | $184.2M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 31 |
| Under 11 |
| $685K |
| Adnan Akhtar Kissimmee, FL | Hematology-Oncology | 27 | Under 11 | $611K |
| Hyo S Han Tampa, FL | Hematology-Oncology | 23 | Under 11 | $499K |
| Bilal Ansari Mishawaka, IN | Medical Oncology | 27 | Under 11 | $491K |
| Rebecca A Shatsky La Jolla, CA | Hematology-Oncology | 21 | Under 11 | $475K |
| Leonid Shunyakov Bolivar, MO | Medical Oncology | 24 | Under 11 | $467K |
| Melanie Clark Fort Wayne, IN | Hematology-Oncology | 20 | Under 11 | $467K |
| Meredith Faggen S Weymouth, MA | Hematology-Oncology | 23 | Under 11 | $464K |
| Neeraj Mahajan Wadsworth, OH | Hematology | 20 | Under 11 | $461K |
| Lindsey H Prochaska Wilmington, NC | Hematology-Oncology | 21 | Under 11 | $460K |
| Rashmi K Menon Torrance, CA | Internal Medicine | 22 | Under 11 | $460K |
| Rena D Callahan Valencia, CA | Hematology-Oncology | 21 | Under 11 | $432K |
| Dayra C Avila Lima Jacksonville, FL | Hematology-Oncology | 26 | Under 11 | $424K |
| Jean G Bustamante New York, NY | Hematology-Oncology | 19 | Under 11 | $412K |
| Muhammad H Imam Winter Park, FL | Hematology-Oncology | 18 | Under 11 | $412K |
| George J David Sacramento, CA | Pharmacist | 17 | Under 11 | $410K |
| Michael P Castro Los Angeles, CA | Hematology-Oncology | 18 | Under 11 | $408K |
| Debra A Patt Austin, TX | Medical Oncology | 18 | Under 11 | $405K |
| Joseph F McLaughlin Manchester, CT | Hematology-Oncology | 18 | Under 11 | $403K |
| William Gradishar Chicago, IL | Medical Oncology | 24 | Under 11 | $401K |
| Elisabeth A McKeen Palm Beach Gardens, FL | Hematology-Oncology | 21 | Under 11 | $398K |
| Shannon L Huggins-Puhalla Pittsburgh, PA | Medical Oncology | 17 | Under 11 | $391K |
| Katelin A Winiger Louisville, KY | Nurse Practitioner | 18 | Under 11 | $388K |
| Spending |
|---|
| Astrazeneca AZN | 8,670 | $184.2M |